Stocktoria
BIOLARGO, INC. BLGO
OTC · OOTC · stock · Chemicals & Allied Products · website · IPO 1991-12-12
BIOLARGO, INC. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8M | $17.8M | $12.2M | $5.9M | $2.5M | $2.4M | $1.9M | $1.4M | $516,213 | $281,106 |
| Gross profit | $3.4M | $7.9M | $6.2M | $2.9M | $1.1M | $1.2M | $916,000 | $621,000 | $193,000 | $175,229 |
| R&D expense | $2.6M | $2.9M | $2.3M | $1.3M | $1.4M | $1.3M | $1.5M | $1.7M | $1.6M | $1.4M |
| SG&A expense | $11.8M | $9.3M | $8.1M | $6.7M | $6.2M | $7.5M | $6.1M | $5.3M | $4.4M | $3.7M |
| Operating income | -$14.9M | -$4.3M | -$4.6M | -$5.4M | -$6.8M | -$7.6M | -$6.7M | -$6.4M | -$5.9M | -$4.9M |
| Interest expense | — | — | $91,000 | $53,000 | $234,000 | $1.9M | $4.0M | $3.5M | $3.9M | $3.1M |
| Income tax | — | $0 | $0 | — | — | — | — | — | — | — |
| Operating cash flow | -$8.3M | -$3.2M | -$2.4M | -$2.8M | -$3.9M | -$4.2M | -$4.4M | -$3.9M | -$4.3M | -$3.7M |
| Free cash flow | — | — | — | — | — | — | — | — | -$4.3M | — |
| Cash & equivalents | $3.9M | $3.5M | $3.5M | $1.9M | $962,000 | $716,000 | $655,000 | $655,000 | $990,000 | $1.9M |
| Inventory | $310,000 | $330,000 | $153,000 | $120,000 | $241,000 | $277,000 | $16,000 | $26,000 | $54,000 | $34,446 |
| Total assets | $8.3M | $10.5M | $8.2M | $4.9M | $3.0M | $4.9M | $3.6M | $3.2M | $1.5M | $2.1M |
| Total liabilities | $6.8M | $4.5M | $4.0M | $2.8M | $2.1M | $5.2M | $5.8M | $4.3M | $4.9M | $2.9M |
| Shareholders' equity | $4.0M | $8.9M | $6.8M | $4.9M | $4.7M | $3.9M | -$2.2M | -$1.5M | -$4.1M | -$1.3M |
Growth · year-over-year · Revenue CAGR 44.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -56.3% | +45.4% | +107.9% | +132.5% | +4.1% | +30.7% | +36.4% | +164.2% | +83.6% | +120.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000880242 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.